Global Oncology Academy

Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Clinician's Roundtable
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
- Pedro Nascimento de Lima, PhD
Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
Project Oncology®
Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
- Charles Turck, PharmD, BCPS, BCCCP
- Sairah Ahmed, MD
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Project Oncology®
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
- Brian Slomovitz, MD
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Project Oncology®
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
- Brian Slomovitz, MD
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Project Oncology®
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Clinician's Roundtable
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
- Charles Turck, PharmD, BCPS, BCCCP
- Gloria Coronado, PhD
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
MinuteCE®
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
1.00 program credit
- John M. Kirkwood, MD
- Sapna Patel, MD
1.00 program credit

Medical News

Medical News
MRI-Derived Sarcopenia: A New Prognostic Marker in Endometrial Cancer
08/08/2025
Read more
Medical News
Harnessing Dual Capabilities of the Immune System in Oncology and Allergy
08/07/2025
Read more
Medical News
Closing the Gap in Colorectal Cancer Screening Adherence
08/07/2025
Read more
Medical News
Transforming Prostate Cancer Treatment: Novel Therapies and Surgical Advances
08/07/2025
Read more

See more news

CME/CE

Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
MinuteCE®
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
1.00 program credit
- Paolo A. Ascierto, MD
1.00 program credit
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
MinuteCE®
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
The Safety Balancing Act – Mastering Adverse Event Management 
The Safety Balancing Act – Mastering Adverse Event Management 
MinuteCE®
The Safety Balancing Act – Mastering Adverse Event Management 
1.00 program credit
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 program credit
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
MinuteCE®
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits

Clinical Practice

Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
Project Oncology®
Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
- Jacob Sands, MD
- Christine Bestvina, MD
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Project Oncology®
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
- Charles Turck, PharmD, BCPS, BCCCP
- Hope S. Rugo, MD, FASCO
Putting Patients First: Personalized Care in Metastatic Breast Cancer
Putting Patients First: Personalized Care in Metastatic Breast Cancer
Global Oncology Academy
Putting Patients First: Personalized Care in Metastatic Breast Cancer
- Ashley Baker, MSN, PMHNP
- Giancarlo Moscol, M.D.
Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
Project Oncology®
Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
- Charles Turck, PharmD, BCPS, BCCCP
- Matthew Lunning, DO, FACP

Programs

Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
Project Oncology®
Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
- Charles Turck, PharmD, BCPS, BCCCP
- Neil M. Iyengar, MD
- Komal Jhaveri, MD, FACP
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Project Oncology®
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
- Charles Turck, PharmD, BCPS, BCCCP
- Neil M. Iyengar, MD
MinuteCE®
Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer
1.25 credits 9 episodes
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 credits 9 episodes
Applications of Emerging Data in Resectable NSCLC
Applications of Emerging Data in Resectable NSCLC
MinuteCE®
Applications of Emerging Data in Resectable NSCLC
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits